Tag: Kenvue

Johnson & Johnson’s Consumer Health Spinoff Kenvue Becomes US Largest IPO since 2021

Posted on May 5, 2023 by admin

Regardless of the success of Kenvue’s IPO, Johnson & Johnson stays underneath allegations that a few of its talc merchandise are cancerous. Kenvue, the consumer-health spinoff announced by Johnson &….

Market

Johnson & Johnson Details Launch Plans Regarding Kenvue IPO Roadshow

Posted on April 25, 2023April 25, 2023 by admin

Pharmaceutical powerhouse J&J expects to cost its Kenvue IPO shares at $20 to $23 for a possible $40 billion firm valuation. Johnson & Johnson (NYSE: JNJ) plans to cost shares of….